Riskpilot← Back to searchSign inGet full accessMEDISYD AS
ASActiveOrg 979445415Vestre Rosten 79, 7075 TillerGeneral medical practice activities · NACE 8621Est. 19979 employees
Revenue 2024
NOK 7,3M
+4% vs 2023
EBITDA margin
2.5%
+140% vs 2023
Equity ratio
30.2%
Financial strength
Net profit 2024
NOK 22K
+105% vs 2023
| Revenue | NOK 7,3M | +4% |
| EBITDA | NOK 184K | +140% |
| Net profit | NOK 22K | +105% |
| Total assets | NOK 1,3M | -21% |
| Equity | NOK 385K | +6% |
| Employees | 9 | — |
Legal name
MEDISYD AS
Org number
979445415
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
14. oktober 1997
Share capital
NOK 160 000
Employees
9 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Drift av legekontor, andre salg/tjenester som naturlig hører sammen med dette.
Address
Vestre Rosten 79, 7075 Tiller
Phone
+4772887755
Email
post@medisyd.nhn.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 866 | 7 365 | 7 796 | 7 024 | 7 330 |
| Staff expenses | −3 241 | −3 580 | −3 325 | −3 888 | −3 782 |
| EBITDA | 265 | 223 | 833 | −457 | 184 |
| Depreciation & amort. | −230 | −200 | −188 | −155 | −155 |
| EBIT | 35 | 23 | 645 | −612 | 28 |
| Net financials | −35 | −20 | −9 | −6 | −0 |
| Profit before tax | −0 | 3 | 636 | −617 | 28 |
| Tax | 1 | 1 | 142 | −135 | 6 |
| Net profit | −1 | 2 | 494 | −482 | 22 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 771 | 1 653 | 1 861 | 1 607 | 1 275 |
| Equity | 349 | 351 | 845 | 363 | 385 |
| Long-term debt | 389 | 146 | 0 | 0 | 0 |
| Short-term debt | 1 034 | 1 156 | 1 016 | 1 245 | 890 |
| Total debt | 1 422 | 1 302 | 1 016 | 1 245 | 890 |
EBITDA margin
2.5%
This company
15.8%
Market median
-84% vs market
20202024
Equity ratio
30.2%
This company
38.2%
Market median
+21% vs market
20202024
Return on equity
5.7%
This company
18.4%
Market median
-69% vs market
20202024
Net profit margin
0.3%
This company
8.1%
Market median
-96% vs market
20202024
Asset turnover
5.75×
This company
1.12×
Market median
+413% vs market
20202024
Debt / equity
2.31×
This company
0.62×
Market median
-273% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2024 | |
| Former (1) | ||
| Board of Directors | 2017 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 14.31% | 14.31% | 2023 | |
| Individual | 14.31% | 14.31% | 2023 | |
| Individual | 14.31% | 14.31% | 2023 | |
| Individual | 14.31% | 14.31% | 2023 | |
| Individual | 14.31% | 14.31% | 2022 | |
| Individual | 14.25% | 14.25% | 2023 | |
| Individual | 14.25% | 14.25% | 2023 | |
| Individual | 14.25% | 14.25% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MEDISYD AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sigurd Baldersheim | Board of Directors | 0 companies |
| Ivar Morten Jørum | Board of Directors | 0 companies |